Cafepharma Today

January 29 2025 - How might the FDA evolve under RFK Jr. and Makary?
How might the FDA evolve under RFK Jr. and Makary?
US government agencies file objection to J&J's $9B talc bankruptcy settlement
Teva Pharmaceutical posts lower revenue
Troubled 23andMe is exploring a sale of the business
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Pills and Politics: The normally GOP-friendly drug industry now favors Obama
Slate
Wednesday, August 27, 2008 - 12:03pm
tags:
When it rains risk it pours; within a 12-hour period five biopharma companies revealed negative drug news that is sending their stocks lower
CNBC
Wednesday, August 27, 2008 - 12:00pm
tags:
Drug maker Schering-Plough wins EU OK to sell animal medicines to rival Pfizer
Yahoo/AP
Wednesday, August 27, 2008 - 11:56am
tags:
Will hostile takeovers become the norm for drugmakers?
Bizmology
Wednesday, August 27, 2008 - 10:15am
tags:
Amylin Tumbles After Four More Patients Die While Using Byetta
Bloomberg
Wednesday, August 27, 2008 - 10:01am
tags:
The Early Edge: Amylin Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly, and Pfizer
Schaeffer's Research
Wednesday, August 27, 2008 - 10:00am
tags:
A Failure Makes Bristol’s Deal With Pfizer Look Smart
WSJ Online
Wednesday, August 27, 2008 - 8:48am
tags:
Pain Therapeutics and King Pharmaceuticals Develop a New Abuse-Resistant Prescription Pain Medication
Trading Markets
Wednesday, August 27, 2008 - 8:41am
tags:
AstraZeneca Adds an Electronic Component to Physician Mailers
PharmExec
Wednesday, August 27, 2008 - 8:12am
tags:
New FDA Rules Say When Pharma Can Act Alone
PharmExec
Wednesday, August 27, 2008 - 8:10am
tags:
Novavax Moves Closer to Licensing Bird Flu Vaccine
Washington Post, DC
Wednesday, August 27, 2008 - 7:26am
tags:
Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer
Yahoo
Wednesday, August 27, 2008 - 7:24am
tags:
Novartis' Cancer Drug Glivec Gets Fast-Track Review
Bloomberg
Wednesday, August 27, 2008 - 7:23am
tags:
Sun Pharma Wins Case Against Taro in Israeli Court
Bloomberg
Wednesday, August 27, 2008 - 7:23am
tags:
Novartis says blindness drug Lucentis receives universal funding approval in Britain
Yahoo/AP
Wednesday, August 27, 2008 - 7:22am
tags:
Pfizer Vs. Johnson & Johnson
CNBC
Wednesday, August 27, 2008 - 7:21am
tags:
Lilly, Amylin Disclose More Cases of Byetta-Related Pancreatitis
WSJ Online
Tuesday, August 26, 2008 - 5:34pm
tags:
NexMed shares sink on Novartis decision
Yahoo/AP
Tuesday, August 26, 2008 - 5:32pm
tags:
J&J Schizophrenia Drug Faces FDA Delay
TheStreet.com
Tuesday, August 26, 2008 - 5:31pm
tags:
Bristol, Pfizer to delay clot drug after setback
Reuters
Tuesday, August 26, 2008 - 5:30pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information